Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Contraception and Contraceptive Drugs

Free Subscription Articles published in JAMA Retrieve available abstracts of 45 articles: HTML format

Single Articles

July 2024
1. QATO DM, Guadamuz JS, Myerson R
   Changes in Emergency Contraceptive Fills After Massachusetts' Statewide Standing Order.
   JAMA. 2024 Jul 2:e2411715. doi: 10.1001/jama.2024.11715.
   PubMed    
   
   
   June 2024
2. HARRIS E
   Receiving Abortion Medication Through Mail Was Safe, Effective.
   JAMA. 2024 Jun 7. doi: 10.1001/jama.2024.10330.
   PubMed    
   
   
   May 2024
3. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
   The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
   JAMA. 2024;331:1748-1760.
   PubMed     Abstract available
   
   
   
4. ESPEY E, Hailstorks T, Hofler L
   Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine.
   JAMA. 2024;331:1529-1530.
   PubMed    
   
   
   April 2024
5. HARRIS E
   Over-the-Counter Birth Control Pill Now Available in US.
   JAMA. 2024;331:1354.
   PubMed    
   
   
   
6. HARRIS E
   Use of Progestogen Tied to Higher Chance of Benign Brain Tumor.
   JAMA. 2024 Apr 19. doi: 10.1001/jama.2024.5923.
   PubMed    
   
   
   March 2024
7. FERNANDEZ LYNCH H, Kesselheim AS
   The FDA in the Crosshairs-Science, Politics, and Abortion.
   JAMA. 2024 Mar 25. doi: 10.1001/jama.2024.2229.
   PubMed    
   
   
   
8. AIKEN ARA, Wells ES, Gomperts R, Scott JG, et al
   Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision.
   JAMA. 2024 Mar 25:e244266. doi: 10.1001/jama.2024.4266.
   PubMed     Abstract available
   
   
   October 2023
9. MEEGAN MA
   Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access.
   JAMA. 2023 Oct 26. doi: 10.1001/jama.2023.21591.
   PubMed    
   
   
   September 2023
10. HARRIS E
    Blot Clot Risk Higher When Pain Relievers Used With Hormonal Contraception.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17823.
    PubMed    
    
    
    
11. FLEURANT E, Mokashi M, Simon MA
    Over-the-Counter Progestin-Only Oral Contraceptives.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17781.
    PubMed    
    
    
    August 2023
12. HARRIS E
    FDA Greenlights First Over-the-Counter Oral Birth Control.
    JAMA. 2023;330:585.
    PubMed    
    
    
    July 2023
13. JUGL S, Winterstein AG
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
    JAMA. 2023;330:378.
    PubMed    
    
    
    
14. MEAIDI A, Torp-Pedersen C, Morch LS
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
    JAMA. 2023;330:378-379.
    PubMed    
    
    
    
15. BOOS EW, Horta M, Thompson I, Dusetzina SB, et al
    Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
    JAMA. 2023 Jul 21. doi: 10.1001/jama.2023.13628.
    PubMed    
    
    
    
16. BRANDI K, Upadhya KK, Teal SB
    Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity.
    JAMA. 2023 Jul 14. doi: 10.1001/jama.2023.10825.
    PubMed    
    
    
    June 2023
17. RUBIN R
    Over-the-Counter Birth Control Pill Could Be Available in the US by Year's End.
    JAMA. 2023;329:2009-2010.
    PubMed    
    
    
    
18. GLUCK AR
    The Mifepristone Case and the Legitimacy of the FDA.
    JAMA. 2023 Jun 2. doi: 10.1001/jama.2023.8712.
    PubMed    
    
    
    April 2023
19. AARON DG, Brown TR, Sinha MS
    Court Intrusion Into Science and Medicine-the Mifepristone Decisions.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.7790.
    PubMed    
    
    
    March 2023
20. MEAIDI A, Torp-Pedersen C, Lidegaard O, Morch LS, et al
    Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
    JAMA. 2023;329:935-937.
    PubMed    
    
    
    
21. AVERBACH S, Kully G, Hinz E, Dey A, et al
    Early vs Interval Postpartum Intrauterine Device Placement: A Randomized Clinical Trial.
    JAMA. 2023;329:910-917.
    PubMed     Abstract available
    
    
    
22. HARRIS E
    On-Demand Male Contraceptive Compound Promising in Mouse Study.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2888.
    PubMed    
    
    
    February 2023
23. CRANDALL CJ, Mehta JM, Manson JE
    Management of Menopausal Symptoms: A Review.
    JAMA. 2023;329:405-420.
    PubMed     Abstract available
    
    
    December 2022
24. ROLAND N, Baricault B, Weill A, Bouillon K, et al
    Association Between Doses of Levonorgestrel Intrauterine Systems and Subsequent Use of Psychotropic Drugs in France.
    JAMA. 2022 Dec 22. doi: 10.1001/jama.2022.21471.
    PubMed    
    
    
    August 2022
25. COHEN RH, Teal SB
    Medication Abortion.
    JAMA. 2022 Aug 19. pii: 2795652. doi: 10.1001/jama.2022.14805.
    PubMed    
    
    
    
26. STARK EL, Gariepy AM, Son M
    What Is Long-Acting Reversible Contraception?
    JAMA. 2022 Aug 12. pii: 2795467. doi: 10.1001/jama.2022.14239.
    PubMed    
    
    
    July 2022
27. SLOMSKI A
    Emergency Contraception Caution for Women With Obesity.
    JAMA. 2022;328:322.
    PubMed    
    
    
    
28. LINDLEY KJ, Teal SB
    Contraception in Women With Cardiovascular Disease.
    JAMA. 2022 Jul 22. pii: 2794754. doi: 10.1001/jama.2022.11541.
    PubMed    
    
    
    June 2022
29. COHEN RH, Teal SB
    Medication for Early Pregnancy Termination.
    JAMA. 2022 Jun 2. pii: 2793170. doi: 10.1001/jama.2022.6344.
    PubMed    
    
    
    May 2022
30. AVERBACH S, Hofler L
    Long-Acting Reversible Contraception With Contraceptive Implants and Intrauterine Devices.
    JAMA. 2022 May 6. pii: 2792212. doi: 10.1001/jama.2022.5448.
    PubMed    
    
    
    April 2022
31. SKARITANOV E, Wilkie G, Kovell LC
    Selection, Effectiveness, and Adverse Effects of Contraception.
    JAMA. 2022;327:1504.
    PubMed    
    
    
    
32. TEAL S, Edelman A
    Selection, Effectiveness, and Adverse Effects of Contraception-Reply.
    JAMA. 2022;327:1505.
    PubMed    
    
    
    January 2022
33. HUDDLESTON HG, Dokras A
    Diagnosis and Treatment of Polycystic Ovary Syndrome.
    JAMA. 2022;327:274-275.
    PubMed    
    
    
    
34. SPECTOR LG, Moertel CL, Su HI
    Maternal Contraceptive Use and Central Nervous System Tumors in Offspring.
    JAMA. 2022;327:39-40.
    PubMed    
    
    
    
35. HARGREAVE M, Morch LS, Winther JF, Schmiegelow K, et al
    Association Between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children.
    JAMA. 2022;327:59-66.
    PubMed     Abstract available
    
    
    December 2021
36. TEAL S, Edelman A
    Contraception Selection, Effectiveness, and Adverse Effects: A Review.
    JAMA. 2021;326:2507-2518.
    PubMed     Abstract available
    
    
    
37. RUBIN R
    Expanding Access to Medication Abortions.
    JAMA. 2021 Dec 22. pii: 2787610. doi: 10.1001/jama.2021.23357.
    PubMed    
    
    
    November 2021
38. EICHENFIELD DZ, Sprague J, Eichenfield LF
    Management of Acne Vulgaris: A Review.
    JAMA. 2021;326:2055-2067.
    PubMed     Abstract available
    
    
    
39. PITTS S, DiVasta AD, Gordon CM
    Evaluation and Management of Amenorrhea.
    JAMA. 2021;326:1962-1963.
    PubMed    
    
    
    
40. BALKUS JE, Dionne-Odom J, Wiesenfeld HC
    Contraception Requirements in Clinical Trials: Considerations From Studies on Sexually Transmitted Infections.
    JAMA. 2021 Nov 3. pii: 2786022. doi: 10.1001/jama.2021.19473.
    PubMed    
    
    
    October 2021
41. KAUNITZ AM, Kapoor E, Faubion S
    Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause.
    JAMA. 2021;326:1429-1430.
    PubMed    
    
    
    August 2021
42. 
    Phexxi-A Nonhormonal Contraceptive Gel.
    JAMA. 2021;326:763-764.
    PubMed    
    
    
    July 2021
43. KUEHN BM
    CDC Recommends Self-injected Contraceptive Option.
    JAMA. 2021;326:125.
    PubMed    
    
    
    December 2019
44. KHO KA, Shields JK
    Diagnosis and Management of Primary Dysmenorrhea.
    JAMA. 2019 Dec 19. pii: 2758078. doi: 10.1001/jama.2019.16921.
    PubMed    
    
    
    
45. DOUGLASS LA, Davis AM
    Assessment and Management of Heavy Menstrual Bleeding.
    JAMA. 2019 Dec 19. pii: 2758077. doi: 10.1001/jama.2019.17383.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.